Company Name: |
Molcoo Chemicals Inc.
|
Tel: |
18576690171 17386083646 |
Email: |
3001006472@qq.com |
Products Intro: |
Product Name:Dolutegravir Impurity 23 CAS:1802141-49-6 Purity:95% Package:20mg;50mg;100mg
|
Company Name: |
Shenzhen Roark Pharma-Tec Co., Ltd.
|
Tel: |
13128912434 |
Email: |
2880126944@qq.com |
Products Intro: |
Product Name:Dolutegravir Impurity 32 CAS:1802141-49-6 Purity:98% HPLC Package:10MG;25MG;50MG;100MG
|
Company Name: |
guoyungurui
|
Tel: |
18162595016; 18162595016 |
Email: |
3287908757@qq.com |
Products Intro: |
Product Name:Syringaresinol Impurity 1(Syringaresinol Diglucoside) CAS:1802141-49-6 Purity:95%+HPLC Package:10mg;25mg;50mg;100mg;200mg
|
|
| Dolutegravir Impurity C Basic information |
Product Name: | Dolutegravir Impurity C | Synonyms: | Dolutegravir Impurity 20;(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1,2:;Dolutegravir Impurity 23;(4R,12aS)-N-(2,4-difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1'',2'':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-7-ethoxy-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-, (4R,12aS)-;Dolutegravir Impurity 32;Syringaresinol Impurity 1(Syringaresinol Diglucoside);Durutevir impurity 23 | CAS: | 1802141-49-6 | MF: | C22H23F2N3O5 | MW: | 447.43 | EINECS: | | Product Categories: | | Mol File: | 1802141-49-6.mol | ![Dolutegravir Impurity C Structure](CAS/20210111/GIF/1802141-49-6.gif) |
| Dolutegravir Impurity C Chemical Properties |
Boiling point | 688.1±55.0 °C(Predicted) | density | 1.42±0.1 g/cm3(Predicted) | pka | 10.71±0.40(Predicted) |
| Dolutegravir Impurity C Usage And Synthesis |
Uses | O-Ethyl Dolutegravir is an impurity of Dolutegravir (D528800), which is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. |
| Dolutegravir Impurity C Preparation Products And Raw materials |
|